ViaZen Articulation/Joint
Natural health product licensed in Canada
- Licence holder
- Distripharm Inc.
- NPN or DIN-HM
- 80081970
- Status
- Active licence
- Licence date
- 20 December 2017
- Revision date
- 13 October 2020
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Dose déclarée au-delà d'une limite
Cuivre: up to 4,000 µg a day according to the dosing instructions published by Health Canada (2 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 2,000 µg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- Conditions légales
Urtica dioica L.: L'étiquetage des compléments alimentaires contenant les parties souterraines de cette plante doit comporter une mention recommandant de prendre conseil auprès d'un professionnel de santé ("Demander l'avis de votre médecin et /ou pharmacien").
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Urtica dioica Source : Sommité Extract : Matériel brut sec Extraction ratio : 20:1 Dry plant equivalent : 2,000 milligramme | 100 milligramme | Not calculated |
| Harpagophytum procumbens Source : Racine(s) secondaire(s) tubérisée(s) Extract : Matériel brut sec Extraction ratio : 40:1 Dry plant equivalent : 3,000 milligramme | 75 milligramme | Not calculated |
| L-Lysine Source : L-Lysine | 75 milligramme | Not calculated |
| L-Proline Source : L-Proline | 75 milligramme | Not calculated |
| Acide hyaluronique Source : Sodium hyaluronate from bacterial extracellular capsule of Streptococcus equi | 60 milligramme | Not calculated |
| Vitamine C Source : Acide ascorbique | 30 milligramme | 60,000 µg |
| Cuivre Source : Diglycinate de cuivre (II) | 2 milligramme | 4,000 µg |
Non-medicinal ingredients
Stéarate de magnésium, Cellulose microcristalline, Gélatine, Silicium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 2 Capsule | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Used in Herbal Medicine as supportive therapy to help relieve rheumatic complaints. Used in Herbal Medicine as a nutritive tonic. Used in Herbal Medicine to help relieve joint pain associated with osteoarthritis. Helps in collagen formation. Source of (an) amino acid(s) involved in muscle protein synthesis. Helps support joint health. Helps in the development and maintenance of bones and cartilage. Helps in connective tissue formation. Helps in wound healing. Helps in collagen formation to maintain healthy bones and cartilage. Helps to maintain the body's ability to metabolize nutrients. Helps to produce and repair connective tissue.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80081970
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2020. Photograph the packaging to check whether it has changed. Photograph the packaging